Triomics Secures Over $36M in Funding to Expand Oncology AI Platform

Triomics, an oncology AI company, secures over $36 million in its latest funding round led by Battery Ventures.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here